OTCM vs. NVO

Last updated Jun 9, 2026

OTCM (Otc Markets Group) and NVO (Novo Nordisk A/S) are both stocks. OTCM operates in Financial Data & Stock Exchanges (Financial Services), while NVO operates in Drug Manufacturers - General (Healthcare). Over the past 10 years, OTCM returned 16.86%/yr vs 6.20%/yr for NVO. At a 0.05 correlation, their price movements are largely independent.

Performance

OTCM vs. NVO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Otc Markets Group (OTCM) and Novo Nordisk A/S (NVO). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, OTCM achieves a 2.44% return, which is significantly higher than NVO's -16.56% return. Over the past 10 years, OTCM has outperformed NVO with an annualized return of 16.86%, while NVO has yielded a comparatively lower 6.20% annualized return.

OTCM

• 1D: 0.37%
• 1M: -3.68%
• YTD: 2.44%
• 6M: 4.00%
• 1Y: 7.29%
• 3Y*: 1.51%
• 5Y*: 6.71%
• 10Y*: 16.86%

NVO

• 1D: -4.52%
• 1M: -10.96%
• YTD: -16.56%
• 6M: -9.23%
• 1Y: -42.47%
• 3Y*: -17.53%
• 5Y*: 1.78%
• 10Y*: 6.20%

*Multi-year figures are annualized to reflect compound growth (CAGR)

OTCM vs. NVO - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
OTCM Otc Markets Group	2.44%	5.08%	-4.43%	2.06%	-0.01%	85.79%	0.99%	25.17%	4.17%	32.32%
NVO Novo Nordisk A/S	-16.56%	-39.22%	-15.93%	54.84%	22.66%	63.52%	23.33%	28.70%	-12.98%	52.92%

Correlation

The correlation between OTCM and NVO is -0.01, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	-0.01
Correlation (3Y) Calculated over the trailing 3-year period	0.01
Correlation (5Y) Calculated over the trailing 5-year period	0.02
Correlation (10Y) Calculated over the trailing 10-year period	0.04
Correlation (All Time) Calculated using the full available price history since Jan 24, 2011	0.05

Fundamentals

Market Cap OTCM : $616.38M NVO : $182.49B
EPS OTCM : $2.71 NVO : $27.42
PE Ratio OTCM : 19.15 NVO : 1.50
PEG Ratio OTCM : 53.79 NVO : 0.06
PS Ratio OTCM : 4.96 NVO : 0.56
PB Ratio OTCM : 14.56 NVO : 0.90
Total Revenue (TTM) OTCM : $124.27M NVO : $327.80B
Gross Profit (TTM) OTCM : $60.59M NVO : $268.30B
EBITDA (TTM) OTCM : $42.09M NVO : $181.54B

Return for Risk

OTCM vs. NVO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

OTCM

OTCM Risk / Return Rank: 49
OTCM Sharpe Ratio Rank: 51
OTCM Sortino Ratio Rank: 45
OTCM Omega Ratio Rank: 45
OTCM Calmar Ratio Rank: 52
OTCM Martin Ratio Rank: 51

NVO

NVO Risk / Return Rank: 12
NVO Sharpe Ratio Rank: 9
NVO Sortino Ratio Rank: 12
NVO Omega Ratio Rank: 10
NVO Calmar Ratio Rank: 13
NVO Martin Ratio Rank: 17

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

OTCM vs. NVO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Otc Markets Group (OTCM) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	OTCM	NVO	Difference
Sharpe ratio: Return per unit of total volatility	0.24	-0.82	+1.06
Sortino ratio: Return per unit of downside risk	0.59	-1.01	+1.60
Omega ratio: Gain probability vs. loss probability	1.07	0.86	+0.22
Calmar ratio: Return relative to maximum drawdown	0.42	-0.77	+1.20
Martin ratio: Return relative to average drawdown	0.74	-1.14	+1.88
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

OTCM vs. NVO - Sharpe Ratio Comparison

The current OTCM Sharpe Ratio is 0.24, which is higher than the NVO Sharpe Ratio of -0.82. The chart below compares the historical Sharpe Ratios of OTCM and NVO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	OTCM	NVO	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.24	-0.82	+1.06
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.23	0.05	+0.18
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.51	0.19	+0.32
Sharpe Ratio (All Time) Calculated using the full available price history	0.65	0.47	+0.18

Drawdowns

OTCM vs. NVO - Drawdown Comparison

The maximum OTCM drawdown since its inception was -39.87%, smaller than the maximum NVO drawdown of -74.70%. Use the drawdown chart below to compare losses from any high point for OTCM and NVO.

Drawdown Indicators

	OTCM	NVO	Difference
Max Drawdown Largest peak-to-trough decline	-39.87%	-74.70%	+34.83%
Max Drawdown (1Y) Largest decline over 1 year	-17.26%	-55.03%	+37.77%
Max Drawdown (3Y) Largest decline over 3 years	-24.48%	-74.70%	+50.22%
Max Drawdown (5Y) Largest decline over 5 years	-25.80%	-74.70%	+48.90%
Max Drawdown (10Y) Largest decline over 10 years	-39.87%	-74.70%	+34.83%
Current Drawdown Current decline from peak	-9.56%	-70.19%	+60.63%
Average Drawdown Average peak-to-trough decline	-8.57%	-17.77%	+9.20%
Ulcer Index Depth and duration of drawdowns from previous peaks	9.87%	37.21%	-27.34%

Volatility

OTCM vs. NVO - Volatility Comparison

The current volatility for Otc Markets Group (OTCM) is 6.50%, while Novo Nordisk A/S (NVO) has a volatility of 9.75%. This indicates that OTCM experiences smaller price fluctuations and is considered to be less risky than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	OTCM	NVO	Difference
Volatility (1M) Calculated over the trailing 1-month period	6.50%	9.75%	-3.25%
Volatility (6M) Calculated over the trailing 6-month period	17.81%	38.30%	-20.49%
Volatility (1Y) Calculated over the trailing 1-year period	30.93%	52.08%	-21.15%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	29.85%	38.31%	-8.46%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	33.06%	32.56%	+0.50%

Dividends

OTCM vs. NVO - Dividend Comparison

OTCM's dividend yield for the trailing twelve months is around 5.22%, more than NVO's 4.39% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
NVO Novo Nordisk A/S	4.39%	3.31%	1.68%	1.00%	1.20%	1.35%	1.87%	2.14%	1.45%	1.52%	2.87%	0.92%
OTCM Otc Markets Group	5.22%	4.81%	4.33%	3.97%	3.90%	6.19%	3.68%	3.57%	4.24%	3.99%	2.43%	6.63%

Financials

OTCM vs. NVO - Profitability Comparison

The chart below illustrates the profitability comparison between Otc Markets Group and Novo Nordisk A/S over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

OTCM - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Otc Markets Group reported a gross profit of 12.61M and revenue of 30.40M. Therefore, the gross margin over that period was 41.5%.

NVO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported a gross profit of 83.23B and revenue of 96.82B. Therefore, the gross margin over that period was 86.0%.

OTCM - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Otc Markets Group reported an operating income of 8.62M and revenue of 30.40M, resulting in an operating margin of 28.4%.

NVO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported an operating income of 59.62B and revenue of 96.82B, resulting in an operating margin of 61.6%.

OTCM - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Otc Markets Group reported a net income of 7.08M and revenue of 30.40M, resulting in a net margin of 23.3%.

NVO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported a net income of 48.56B and revenue of 96.82B, resulting in a net margin of 50.2%.

Frequently Asked Questions

Can I hold both OTCM and NVO in my portfolio?

OTCM and NVO have a correlation of -0.01, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, OTCM or NVO?

NVO has higher volatility (9.75%) compared to OTCM (6.50%). In terms of maximum drawdown, OTCM dropped -39.87% vs NVO's -74.70%.

Which has better risk-adjusted returns?

OTCM currently has the higher Sharpe Ratio (0.24 vs -0.82), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.